SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Trading Statement

13 Feb 2009 07:00

RNS Number : 2500N
Aukett Fitzroy Robinson Group PLC
13 February 2009
 



For release at 07.00, February 13, 2009

Aukett Fitzroy Robinson Group plc 

("Aukett" or the "Company)

TRADING UPDATE

RUSSIAN CONTRACT EXTENSION

In the recent preliminary results of 15th January the Company announced the signing of a 4,000,000 sq ft office complex for a major Russian financial institution. We are now pleased to advise that instructions have been received and a large advance payment made by the developer client to progress to a planning application this year. This will result in a significant uplift in the Russian operation's income and profits for the current year.

The board's stated intention has been to diversify revenue streams away from the deteriorating UK market and this has proved to be a successful strategy with good progress being made in both Russia and the Middle East. We continue to receive a number of enquires in Russia and have signed further project contracts in Moscow notwithstanding the fact that the Russian market is, in general, experiencing similar funding issues with property projects resulting in widespread deferrals of project starts.

The company stated in the recent preliminary results that it would be necessary to review the UK cost base in view of the decline in the UK market. The outlook for the UK has worsened since January with a number of projects experiencing delays. As a result further cost cuts have been made and the impact of this restructuring will be seen in the first half.

As a result of the continued growth in our overseas operations, compensating for the problems in the UK market, the Board remains confident that it will achieve market expectations for the full year. Due to the large advance payment from Russia, as referred to above, revenue will be increasingly dominated by non-UK based project income. 

Overall it is anticipated that improvement in second half profitability should more than offset the restructuring costs of the first half and the group will continue to be cash generative.

Nicholas Thompson

Chief Executive

Enquiries:

Aukett Fitzroy Robinson - 020 7636 8033Nicholas Thompson, Chief Executive OfficerDuncan Harper, Group Finance Director

FinnCap - 020 7600 1658Sam SmithClive Carver

Adventis Financial PR - 020 7034 4759 / 4758Chris SteeleTarquin Edwards

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMGGMZVZKGLZM
Date   Source Headline
8th Dec 202212:40 pmRNSBoard Changes
17th Nov 20229:00 amRNSHolding(s) in Company
5th Oct 20223:15 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSHolding(s) in Company
4th Aug 20223:27 pmRNSHolding(s) in Company
4th Aug 20223:24 pmRNSHolding(s) in Company
25th Jul 202210:53 amRNSCompletion of Nominated Adviser Due Diligence
29th Jun 20227:00 amRNSInterim Results
7th Jun 20226:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
28th Apr 20227:00 amRNSAppointment of Nominated Adviser
26th Apr 20227:00 amRNSAnnouncement of results of AGM
11th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSAnnouncement of final results for the year end
28th Feb 20228:45 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSGrant of Options to a director
29th Jun 20217:00 amRNSInterim results
29th Mar 20212:47 pmRNSResult of AGM
4th Mar 20217:00 amRNSNotice of AGM, Annual Report and Accounts
18th Feb 20217:00 amRNSAnnouncement of final audited results
1st Feb 20217:00 amRNSBuilding Design Survey Ranking
9th Nov 20207:45 amRNSTrading Statement
2nd Nov 20208:00 amRNSAppointment of Nominated Adviser and Sole Broker
2nd Nov 20207:00 amRNSAIM Rule 17 Schedule 2(g) Update
14th Oct 20205:15 pmRNSHolding(s) in Company
24th Aug 20205:57 pmRNSGrant of Options to a Director
24th Jun 20207:00 amRNSInterim Results
26th Mar 20201:46 pmRNSResult of AGM
26th Mar 20207:00 amRNSAGM Statement
30th Jan 20207:00 amRNSFinal Results
4th Nov 20197:00 amRNSTrading Update
29th Jul 20197:00 amRNSCity Heritage Award
9th Jul 20199:52 amRNSBoard change
28th Jun 20197:00 amRNSInterim Results
24th Jun 20192:14 pmRNSNotice of Interim Results
24th Jun 201910:49 amRNSSamanea Market Dubai
10th May 201912:06 pmRNSDirector Appointment
8th Apr 20197:00 amRNSTrading Update
28th Mar 201911:16 amRNSResult of AGM
28th Mar 20197:00 amRNSAGM Statement
25th Mar 20199:49 amRNSBoard changes
8th Mar 20192:45 pmRNSNotice of Annual General Meeting and Annual Report
5th Feb 20195:42 pmRNSDirectorate Change
30th Jan 20197:00 amRNSFinal Results
8th Jan 20197:00 amRNSNotice of Results
20th Dec 20182:15 pmRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.